Aiforia makes key advancement towards end-to-end clinical pathology workflow solution with the release of its CE-IVD marked Aiforia® Clinical Suite Viewer
Introduction Confused about the evolution of Artificial Intelligence (AI)? What does AI even really mean? Learn more about the facts and fiction of ...
The preclinical phase of drug discovery involves extensive safety evaluations of the potential therapeutic intervention, often using cell and animal models of disease. These studies commonly include going through numerous histopathological samples. This contributes to the drug development process being time-consuming and labor-intensive for pharmaceutical and contract research organizations.
Currently, drug development is very time consuming and labor-intensive. Scientists and pathologists go through hundreds of samples identifying variations to assess how a drug affects a certain tissue or animal. Digital pathology and artificial intelligence (AI) are extremely valuable in this process by improving efficiency. For example, toxicologic pathology research generates a huge number of ...
Introduction Recent advancements in technology have brought together artificial intelligence (AI) and veterinary medicine. As AI models have become accessible through user-friendly platforms, they are now increasingly being utilized by pathologists in both preclinical research and clinical assessment. Veterinary pathologists study disease in animals. They serve as some of the leading experts in ...